| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.039 | 0.4 |